Integrating Quantitative MRI and Artificial Intelligence to Improve Prostate Cancer Classification
Start Date
4/1/2021
Completion Date
6/1/2028
Summary
This study evaluates how new magnetic resonance imaging (MRI) and artificial intelligence techniques improve the image quality and quantitative information for future prostate MRI exams in patients with suspicious of confirmed prostate cancer. The MRI and artificial intelligence techniques developed in this study may improve the accuracy in diagnosing prostate cancer in the future using less invasive techniques than what is currently used.
Detailed Description
PRIMARY OBJECTIVES: I. To develop and evaluate quantitative dynamic contrast-enhanced (DCE)-MRI analysis techniques that minimize patient- and scanner-specific variabilities in the calculation of quantitative parameters. II. To develop and evaluate diffusion weighted imaging (DWI) methods that reduce prostate geometric distortion due to patient- and scanner-specific susceptibility and eddy current effects. III. To develop and evaluate multi-class deep learning models that systematically integrate quantitative multi-parametric (mp)-MRI features for accurate detection and classification of clinically significant prostate cancer (csPCa). OUTLINE: RETROSPECTIVE: Patients' medical records are reviewed. PROSPECTIVE: Patients undergo additional 3 Tesla (T) MRI imaging over 30 minutes before, during, or after their standard of care 3T MRI for a total of 1.5 hours.
Eligibility Criteria
Age Range: 18 years to No maximum
Interventions
3 Tesla Magnetic Resonance Imaging
Electronic Health Record Review
Conditions
Locations
UCLA / Jonsson Comprehensive Cancer Center
Los Angeles, California 90095
United States